Her-2 Positive Gastric Cancer

Also known as: HER2 Positive Gastric Cancer / HER2-positive Gastric Cancer / Human epidermal growth factor 2 positive gastric cancer (disorder)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11595Atezolizumab1Active Not Recruiting1
DB00002Cetuximab1Completed1
DB00531Cyclophosphamide1Recruiting1
DB01248Docetaxel1Unknown Status1
DB01073Fludarabine1Recruiting1
DB01229Paclitaxel1Recruiting1
DB14993Pyrotinib1Unknown Status1
DB00072Trastuzumab1Completed1
DB16342Trastuzumab duocarmazine1Recruiting1
DB01101Capecitabine1 / 2Not Yet Recruiting1
DB00002Cetuximab1 / 2Withdrawn1
DB00072Trastuzumab1 / 2Not Yet Recruiting1
DB00072Trastuzumab1 / 2Withdrawn1
DB14962Trastuzumab deruxtecan1 / 2Not Yet Recruiting1
DB11652Tucatinib1 / 2Not Yet Recruiting1
DB08916Afatinib2Withdrawn1
DB14776Camrelizumab2Recruiting1
DB01101Capecitabine2Completed1
DB01101Capecitabine2Recruiting1
DB00515Cisplatin2Recruiting1
DB06186Ipilimumab2Active Not Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB00526Oxaliplatin2Completed1
DB01229Paclitaxel2Recruiting1
DB01229Paclitaxel2Withdrawn1
DB14993Pyrotinib2Recruiting1
DB09256Tegafur2Recruiting1
DB00072Trastuzumab2Completed1
DB00072Trastuzumab2Recruiting1
DB14967Margetuximab2 / 3Recruiting1
DB15766Retifanlimab2 / 3Recruiting1
DB16685Tebotelimab2 / 3Recruiting1
DB00072Trastuzumab2 / 3Recruiting1
DB01101Capecitabine4Unknown Status1
DB00526Oxaliplatin4Unknown Status1
DB00072Trastuzumab4Unknown Status1